高级搜索
立即登录 | 免费注册
当前位置 >   首页 > 期刊文献 > 全球精选文摘 > 文摘导读
预防性人类乳头瘤病毒L1病毒样颗粒疫苗对2级和3级宫颈上皮内瘤样增生及原位腺癌风险的影响:对4项随机化临床试验的联合分析
Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3, and adenocarcinoma in situ: a combined analysis of four randomised clinical trials
Ault KA, for The Future II Study Group  2009/5/27 10:50:39 
【发表评论】 【全球专家评论】
打印| 推荐给好友

Lancet, 2007,
专家评级:
循证评级:
A

      View at Publisher
Abstract

Background:

Cervical cancer and its obligate precursors, cervical intraepithelial neoplasia grades 2 and 3 (CIN2/3), and adenocarcinona in situ (AIS), are caused by oncogenic human papillomavirus (HPV). In this combined analysis of four clinical trials we assessed the effect of prophylactic HPV vaccination on these diseases.

Methods:

20  583 women aged 16–26 years were randomised to receive quadrivalent HPV6/11/16/18 vaccine (n=9087), its HPV16 vaccine component (n=1204), or placebo (n=10 292). They underwent periodic Papanicolaou testing, with colposcopy or biopsy for detected abnormalities. The primary composite endpoint was the combined incidence of HPV16/18-related CIN2/3, AIS, or cervical cancer. These trials are registered at ClinicalTrials.gov, numbers NCT00365378, NCT00365716, NCT00092521, and NCT00092534.

Findings:

Mean follow-up was 3·0 years (SD 0·66) after first dose. In women negative for HPV16 or HPV18 infection during the vaccination regimen (n=17 129, per protocol), vaccine efficacy was 99% for the primary endpoint (95% CI 93–100), meeting the statistical criterion for success. In an intention-to-treat analysis of all randomised women (including those who were HPV16/18 naive or HPV16/18-infected at day 1), efficacy was 44% (95% CI 31–55); all but one case in vaccine recipients occurred in women infected with HPV16 or HPV18 before vaccination. In a second intention-to-treat analysis we noted an 18% reduction (95% CI 7–29) in the overall rate of CIN2/3 or AIS due to any HPV type.

Interpretation:

Administration of HPV vaccine to HPV-naive women, and women who are already sexually active, could substantially reduce the incidence of HPV16/18-related cervical precancers and cervical cancer.
  评论

请登录后发表评论,点击此处登录。

疾病资源中心  疾病资源中心
病例分析 <span class="ModTitle_Intro_Right" id="EPMI_Home_MedicalCases_Intro_div" onclick="javascript:window.location='http://www.elseviermed.cn/tabid/127/Default.aspx'" onmouseover="javascript:document.getElementById('EPMI_Home_MedicalCases_Intro_div').style.cursor='pointer';document.getElementById('EPMI_Home_MedicalCases_Intro_div').style.textDecoration='underline';" onmouseout="javascript:document.getElementById('EPMI_Home_MedicalCases_Intro_div').style.textDecoration='none';">[栏目介绍]</span>  病例分析 [栏目介绍]

四川省人民医院心内科  陈旸 陈栖栖 苏江 刘明江

 

患者,男,70,心累、气紧1年余,加重1入院。1年前无明显诱因开始出现心累、气紧,不伴心悸、胸痛、胸闷及心前区压榨感,能平卧休息。无夜间阵发性呼吸困难,无双下肢水肿,无气喘,无胸闷胸痛,活动明显,休息后可缓解,多次因受凉复发,抗感染治疗可缓解。1周前患者活动时出现心累、气紧加重,伴乏力、大汗继而出现双眼黑蒙、晕倒,无意识丧失,无大小便失禁,持续约1小时后缓解。3天前受凉后再次发生心累、气紧,不能平卧,双下肢水肿,伴咳嗽,咯白色泡沫痰。当地医院住院治疗无缓解,为进 

 

 

 

 

 

 

 

医学数据库  医学数据库



友情链接:中文版柳叶刀 | MD CONSULT | Journals CONSULT | Procedures CONSULT | eClips CONSULT | Imaging CONSULT | 论文吧 | 世界医学书库 | 医心网 | 前沿医学资讯网

公司简介 | 用户协议 | 条件与条款 | 隐私权政策 | 网站地图 | 联系我们

 互联网药品信息服务资格证书 | 卫生局审核意见通知书 | 药监局行政许可决定书 
电信与信息服务业务经营许可证 | 京ICP证070259号 | 京ICP备09068478号

Copyright © 2009 Elsevier. All Rights Reserved.爱思唯尔版权所有